USFDA concludes inspection at Zydus Lifesciences Ahmedabad site with zero observations
Zydus Lifesciences Ahmedabad Topical Manufacturing site gets zero USFDA observations
Ahmedabad: Zydus Lifesciences has informed in a BSE filing that the US Food and Drug Administration (USFDA) has concluded a routine surveillance inspection with NIL observations at the group’s Topical Manufacturing site situated at Changodar in Ahmedabad.
The inspection was conducted from February 10th to 14th, 2025.
Medical Dialogues team had earlier reported that the Company had successfully completed a USFDA surveillance inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility in Ambernath, Maharashtra.
Read also: Zydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations
Zydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Read also: Zydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in US
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.